Adrenomedullin 2 attenuates the pressor but not adrenal responses to angiotensin II in conscious sheep

Peptides

Volumn 31, Issue 5, 2010, Pages 878-882

  Charles, Christopher J ^a   Rademaker, Miriam T ^a   Gary Nicholls, M ^a   Mark Richards, A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Adrenal; Aldosterone; Arterial pressure; Cardiac output; Peripheral resistance

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; INTERMEDIN;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HEART OUTPUT; HEART RATE; HOMEOSTASIS; HORMONE ACTION; HORMONE RESPONSE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; PROTEIN FUNCTION; SHEEP; SODIUM RESTRICTION; VASCULAR RESISTANCE;

ADRENAL GLANDS; ADRENOMEDULLIN; ALDOSTERONE; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; CONSCIOUSNESS; HEMODYNAMICS; HYDROCORTISONE; RENIN; SHEEP;

OVIS ARIES;

EID: 77951258825     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.02.010     Document Type: Article

References (35)

1. Abdelrahman A.M., Pang C.C. Effect of intermedin/adrenomedullin 2 on venous tone in conscious rats. Naunyn Schmiedebergs Arch Pharmacol 2006, 373:376-380.
2. Andreis P.G., Mazzochi G., Rebuffat P., Nussdorfer G.G. Effects of adrenomedullin and proadrenomedullin N-terminal 20 peptide on rat zona glomerulosa cells. Life Sci 1997, 60:1963-1967.
3. Andreis P.G., Tortorella C., Mazzochi G., Nussdorfer G.G. Proadrenomedullin N-terminal 20 peptide inhibits aldosterone secretion from human adrenocortical and Conn's adenoma cells: comparison with adrenomedullin effect. J Clin Endocrinol Metab 1998, 83:253-257.
4. Charles C.J., Rademaker M.T., Richards A.M., Cooper G.J.S., Coy D.H., Jing N.Y., et al. Hemodynamic, hormonal, and renal effects of adrenomedullin in conscious sheep. Am J Physiol 1997, 272:R2040-R2047.
5. Charles C.J., Rademaker M.T., Richards A.M., Cooper G.J.S., Coy D.H., Nicholls M.G. Adrenomedullin attenuates pressor response to angiotensin II in conscious sheep. J Cardiovasc Pharmacol 2000, 36:526-532.
6. Charles C.J., Nicholls M.G., Rademaker M.T., Richards A.M. Comparative actions of adrenomedullin and nitroprusside: interactions with ANG II and norepinephrine. Am J Physiol 2001, 281:R1887-R1894.
7. Charles C.J., Lainchbury J.G., Nicholls M.G., Rademaker M.T., Richards A.M., Troughton R.W. Adrenomedullin and the renin-angiotensin-aldosterone system. Reg Peptides 2003, 112:41-49.
8. Charles C.J., Rademaker M.T., Richards A.M. Hemodynamic, hormonal, and renal actions of adrenomedullin-2 in normal conscious sheep. Endocrinology 2006, 147:1871-1877.
9. De Matteo R., May C.N. Direct coronary vasodilator action of adrenomedullin is mediated by nitric oxide. Br J Pharmacol 2003, 140:1414-1420.
10. Dong F., Taylor M.M., Samson W.K., Ren J. Intermedin (adrenomedullin-2) enhances cardiac contractile function via a protein kinase C- and protein kinase A-dependent pathway in murine ventricular myocytes. J Appl Physiol 2006, 101:778-784.
11. Dunn P.J., Espiner E.A. Outpatient screening tests for primary aldosteronism. Aust NZ J Med 1976, 6:131-135.
12. Fujisawa Y., Nagai Y., Miyatake A., Takei Y., Miura K., Shoukouji T., et al. Renal effects of a new member of adrenomedullin family, adrenomedullin2, in rats. Eur J Pharmacol 2004, 497:75-80.
13. Fujisawa Y., Nagai Y., Miyatake A., Miura K., Shokoji T., Nishiyama A., et al. Roles of adrenomedullin2 in regulating the cardiovascular and sympathetic nervous system in conscious rats. Am J Physiol 2006, 290:H1120-H1127.
14. Fujisawa Y., Nagai Y., Miyatake A., Miura K., Nishiyama A., Kimura S., et al. Effects of adrenomedullin 2 on regional hemodynamics in conscious rats. Eur J Pharmacol 2007, 558:128-132.
15. Hashimoto H., Kitamura K., Kawasaki M., Saito T., Suzuki H., Otsubo H., et al. Adrenomedullin 2/intermedin-like immunoreactivity in the hypothalamus and brainstem of rats. Auton Neurosci Basic Clin 2008, 139:46-54.
16. Kleinert H.D., Maack T., Atlas S.A. Atrial natriuretic factor inhibits angiotensin-, norepinephrine- and potassium-induced vascular contractility. Hypertension 1984, 6(Suppl. I):I-143-I-147.
17. Kobayashi Y., Liu Y.-J., Gonda T., Takei Y. Coronary vasodilatory response to a novel peptide, adrenomedullin 2. Clin Exp Pharmacol Physiol 2004, 31:S49-50.
18. Lainchbury J.G., Cooper G.J.S., Coy D.H., Jiang N.Y., Lewis L.K., Yandle T.G., et al. Adrenomedullin: a hypotensive hormone in man. Clin Sci 1997, 92:467-472.
19. Lainchbury J.G., Nicholls M.G., Espiner E.A., Yandle T.G., Lewis L.K., Richards A.M. Bioactivity and interactions of adrenomedullin and brain natriuretic peptide in patients with heart failure. Hypertension 1999, 34:70-75.
20. Lewis J.G., Manley L., Whitlow J.C., Elder P.A. Production of a monoclonal antibody to cortisol: application to a direct immunosorbent assay of plasma. Steroids 1992, 57:82-85.
21. Lun S., Espiner E.A., Nicholls M.G., Yandle T.G. A direct radioimmunoassay for aldosterone in plasma. Clin Chem 1983, 29:268-271.
22. Mazzochi G., Rebuffat P., Gottardo G., Nussdorfer G.G. Adrenomedullin and calcitonin gene-related peptide inhibit aldosterone secretion in rats, acting via a common receptor. Life Sci 1996, 58:839-844.
23. Morimoto R., Satoh F., Murakami O., Totsune K., Suzuki T., Sasano H., et al. Expression of adrenomedullin2/intermedin in human brain, heart, and kidney. Peptides 2007, 28:1095-1103.
24. Morimoto R., Satoh F., Murakami O., Hirose T., Totsune K., Imai Y., et al. Expression of adrenomedullin 2/intermedin in human adrenal tumors and attached neo-plastic adrenal tumors. J Endocrinol 2008, 198:175-183.
25. Oelkers W., Brown J.J., Fraser R., Lever A.F., Morton J.J., Robertson J.I. Sensitization of the adrenal cortex to angiotensin II and sodium deplete man. Circ Res 1974, 34:69-77.
26. Pan C.S., Yang J.H., Cai D.Y., Zhao J., Gerns H., Yang J., et al. Cardiovascular effects of newly discovered peptide intermedin/adrenomedullin 2. Peptides 2005, 26:1640-1646.
27. Poyner D.R., Sexton P.M., Marshal I., Smith D.M., Quirion R., Born W., et al. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 2002, 54:233-246.
28. Rademaker M.T., Charles C.J., Lewis L.K., Yandle T.G., Cooper G.J.S., Coy D.H., et al. Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure. Circulation 1997, 96:1983-1990.
29. Rademaker M.T., Charles C.J., Nicholls M.G., Richards A.M. Hemodynamic, hormonal and renal actions of adrenomedullin 2 in experimental heart failure. Circ Heart Fail 2008, 1:134-142.
30. Roh J., Chang C.L., Bhalla A., Klein C., Hsu S.Y.T. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes. J Biol Chem 2004, 279:7264-7274.
31. Szokodi I., Kunnunen P., Tavi P., Weckstrom M., Toth M., Ruskoaho H. Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide. Circulation 1998, 97:1062-1070.
32. Takahashi K., Kikuchi K., Maruyama Y., Urabe T., Nakajima K., Sasano H., et al. Immunocytochemical localization of adrenomedullin 2/intermedin-like immunoreactivity in human hypothalamus, heart and kidney. Peptides 2006, 27:1383-1389.
33. Takei Y., Inoue K., Ogoshi M., Kawahara T., Bannai H., Miyano S. Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator. FEBS Lett 2004, 556:53-58.
34. Takei Y., Hyodo S., Katafuchi T., Minamino N. Novel fish-derived adrenomedullin in mammals: structure and possible function. Peptides 2004, 25:1643-1656.
35. Taylor M.M., Bagley S.L., Samson W.K. Intermedin/adrenomedullin-2 acts within central nervous system to elevate blood pressure and inhibit food and water intake. Am J Physiol 2005, 288:R919-R927.